Zhongwei Xu

1.5k total citations
54 papers, 1.0k citations indexed

About

Zhongwei Xu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zhongwei Xu has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Zhongwei Xu's work include CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Zhongwei Xu is often cited by papers focused on CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Zhongwei Xu collaborates with scholars based in China, United States and Sweden. Zhongwei Xu's co-authors include Jiao Luo, Markus W. Büchler, Ruifang Li‐Gao, Diana van Heemst, Raymond Noordam, Jian Zhang, Marc Solioz, Tingmei Chen, Helmut Frieß and Shijia Ding and has published in prestigious journals such as Nature Communications, Blood and Scientific Reports.

In The Last Decade

Zhongwei Xu

47 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongwei Xu China 19 459 259 144 143 118 54 1.0k
Zhengyu Zhang China 20 373 0.8× 185 0.7× 101 0.7× 150 1.0× 212 1.8× 115 1.3k
Florence Lorget United States 13 591 1.3× 184 0.7× 245 1.7× 48 0.3× 96 0.8× 27 1.1k
Griselda A. Cabral-Pacheco Mexico 4 338 0.7× 179 0.7× 53 0.4× 79 0.6× 133 1.1× 8 1.1k
Roselyne Garnotel France 24 418 0.9× 126 0.5× 94 0.7× 122 0.9× 147 1.2× 71 1.4k
Claudia Castruita-De la Rosa Mexico 8 359 0.8× 179 0.7× 51 0.4× 90 0.6× 135 1.1× 12 1.2k
Jee-Bum Lee South Korea 19 317 0.7× 274 1.1× 56 0.4× 190 1.3× 43 0.4× 86 1.0k
Kye Yong Song South Korea 18 322 0.7× 178 0.7× 64 0.4× 99 0.7× 215 1.8× 92 1.3k
Erna Snellman Finland 23 390 0.8× 333 1.3× 68 0.5× 237 1.7× 68 0.6× 73 1.6k
Ning Qu China 17 509 1.1× 60 0.2× 181 1.3× 149 1.0× 90 0.8× 62 1.1k
Xu D China 24 751 1.6× 242 0.9× 107 0.7× 253 1.8× 124 1.1× 135 1.7k

Countries citing papers authored by Zhongwei Xu

Since Specialization
Citations

This map shows the geographic impact of Zhongwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongwei Xu more than expected).

Fields of papers citing papers by Zhongwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongwei Xu. The network helps show where Zhongwei Xu may publish in the future.

Co-authorship network of co-authors of Zhongwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongwei Xu. A scholar is included among the top collaborators of Zhongwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongwei Xu. Zhongwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Shurong, Weimin Xiao, Zhongwei Xu, et al.. (2025). Divergent effects of EDCs on bone maturation: Role of body mass index and puberty. Ecotoxicology and Environmental Safety. 302. 118525–118525.
2.
Sareila, Outi, Bingze Xu, Zhongwei Xu, et al.. (2024). Human MHC Class II and Invariant Chain Knock‐in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis Association. Advanced Science. 11(23). e2401513–e2401513. 6 indexed citations
3.
Li, H., Jin Wang, Ziling Li, et al.. (2024). Quantitative proteomics reveals the mechanism of endoplasmic reticulum stress-mediated pulmonary fibrosis in mice. Heliyon. 10(20). e39150–e39150.
4.
Xu, Zhongwei, et al.. (2024). Fcgr2b and Fcgr3 are the major genetic factors for cartilage antibody‐induced arthritis, overriding the effect of Hc encoding complement C5. European Journal of Immunology. 54(4). e2350659–e2350659. 4 indexed citations
5.
Wang, Xiaoyong, et al.. (2024). Developing CBTC system safety requirement hierarchy through STPA methodology. Heliyon. 10(11). e31776–e31776. 3 indexed citations
7.
Xu, Zhongwei, Guangsheng Du, Qinghua Liu, et al.. (2023). A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging. Materials Today Bio. 19. 100610–100610. 27 indexed citations
8.
Luo, Jiao, Zhongwei Xu, Raymond Noordam, Diana van Heemst, & Ruifang Li‐Gao. (2021). Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study. Journal of Crohn s and Colitis. 16(4). 633–642. 98 indexed citations
9.
Zhou, Chun‐Gao, et al.. (2021). Prostatic Artery Embolization to Achieve Freedom from Catheterization in Patients with Acute Urinary Retention Caused by Benign Prostatic Hyperplasia. Journal of Vascular and Interventional Radiology. 32(7). 1062–1067. 3 indexed citations
11.
Zeng, Shan, Yanwei Luo, Xinlin Liu, et al.. (2018). Trajectories of Circulating Monocyte Subsets After ST-Elevation Myocardial Infarction During Hospitalization: Latent Class Growth Modeling for High-Risk Patient Identification. Journal of Cardiovascular Translational Research. 11(1). 22–32. 12 indexed citations
13.
Xu, Zhongwei, et al.. (2017). Serum metabolomic study for detecting biomarkers of non-traumatic osteonecrosis of the femoral head. Metabolomics. 13(6). 6 indexed citations
14.
Bai, Li, Sujun Zheng, Mei Liu, et al.. (2017). Efficient inhibition of duck hepatitis B virus DNA by the CRISPR/Cas9 system. Molecular Medicine Reports. 16(5). 7199–7204. 15 indexed citations
15.
Xie, Qi, Wei Wei, Yang Liu, et al.. (2017). Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells. Scientific Reports. 7(1). 41089–41089. 44 indexed citations
16.
Yang, Gang, Hua Zhang, Tingmei Chen, et al.. (2016). Metabolic analysis of osteoarthritis subchondral bone based on UPLC/Q-TOF-MS. Analytical and Bioanalytical Chemistry. 408(16). 4275–4286. 42 indexed citations
17.
Zhu, Weiwen, Tingmei Chen, Shijia Ding, et al.. (2016). Metabolomic study of the bone trabecula of osteonecrosis femoral head patients based on UPLC–MS/MS. Metabolomics. 12(3). 29 indexed citations
18.
Li, Ning, Zhongwei Xu, Linhui Zhai, et al.. (2014). Rapid development of proteomics in China: from the perspective of the Human Liver Proteome Project and technology development. Science China Life Sciences. 57(12). 1162–1171. 8 indexed citations
19.
Tu, Yue, et al.. (2012). Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells. International Journal of Molecular Medicine. 31(1). 113–119. 38 indexed citations
20.
Ozawa, Fumiaki, Helmut Friess, Jörg Kleeff, et al.. (2001). Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Cancer Letters. 163(1). 71–81. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026